Catalog Products » Syndecan-1, His, Rabbit
Manual
Manual
COAs

Syndecan-1, His, Rabbit

CD138 (syndecan-1, Sdc-1) is a member of the syndecan family that comprises heparan sulfate proteoglycans. CD138 is significant for cell-cell and cell-matrix interactions.CD138 plays a crucial role in carcinogenesis and is an attractive target for anticancer treatment with heparanase inhibitors and anti-CD138 antibodies for immunotherapy.
$470.00
Z06411-100

Ask us a question
Product Introduction
Species Rabbit
Protein Construction
Syndecan-1 (Leu23-Gly254)_x000D_
Accession # XP_008252990.1		 His
N-term C-term
Purity > 90% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 24.57 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 45-60 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.
Back

Syndecan-1, His, Rabbit

The purity of Syndecan-1, His, Rabbit is greater than 90% as determined by SEC-HPLC. »

Syndecan-1, His, Rabbit

Syndecan-1, His, Rabbit on Bis-Tris PAGE under reduced condition. The purity is greater than 90%. »

<
>

Background
Target Background CD138 (syndecan-1, Sdc-1) is a member of the syndecan family that comprises heparan sulfate proteoglycans. CD138 is significant for cell-cell and cell-matrix interactions.CD138 plays a crucial role in carcinogenesis and is an attractive target for anticancer treatment with heparanase inhibitors and anti-CD138 antibodies for immunotherapy.
Synonyms Syndecan 1; SYND1; CD138; SDC; SDC1
Back

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.